Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMAâs and FDAâs Views on Initial Dual-Therapy
Bjerrum, Ole Jannik, Eichendorff, Sascha, Alkis, Nada BassamVolume:
54
Language:
english
Journal:
Therapeutic Innovation & Regulatory Science
DOI:
10.1007/s43441-019-00057-7
Date:
March, 2020
File:
PDF, 329 KB
english, 2020